Overall Technical outlook

Price Summary

NATCO Pharma Limited's stock opened at 890.0 on 2025-05-30, surged to 897.95, hit a low of 880.35, and closed up -0.74% at 883.4, with 630952 shares traded.
The top price for the stock in the last 52 weeks is 1592.85, with the bottom price being 746.5.
As per recommendations from 12 analysts, NATCOPHARM's future price is expected to span between 710.0 and 1675.0, with a mean price around 1099.3334.

Technicals

Support and Resistance: The price of 883.4 is supported at 821.9 and capped by resistance at 902.85. These levels mark key points for NATCO Pharma Limited where the price could find stability, with 821.9 as a floor and 902.85 as a ceiling.
NATCOPHARM supportResistance 4df9ee
Support/Resistance for NATCOPHARM


Aroon: The AROON is showing a neutral stance, not indicating a clear upward or downward trend for NATCO Pharma Limited. This suggests a period of market balance, where neither side is showing dominance.
NATCOPHARM aroon 4df9ee
Aroon chart for NATCO Pharma Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
NATCOPHARM bbands 4df9ee
Bolinger Bands chart for NATCO Pharma Limited


Parabolic SAR: The PSAR for NATCOPHARM continues to be bullish, establishing a crucial support level that may help maintain the current upward trend. This level of support suggests that the market is poised to continue its positive trajectory, offering a foundation for further growth.
NATCOPHARM psar 4df9ee
Parabolic Stop and Reverse chart for NATCO Pharma Limited


Stochastic: The STOCHASTIC is in a neutral stance for NATCOPHARM, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
NATCOPHARM stoch 4df9ee
Stochastic chart for NATCO Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
NATCOPHARM trippleSMA 4df9ee
Tripple SMA chart for NATCO Pharma Limited


When evaluating a company, it is crucial to examine its fundamentals, including its financial statements, management structure, and market position. Additionally, understanding the broader industry trends, competition, and regulatory landscape helps to create a well-rounded view. By assessing both the company's internal factors and the external environment in which it operates, you can extract more valuable insights from its technical performance, such as stock price movements and trading patterns.